How long does it take to reach a treatment plateau
OctoberDecember 2025: imlunestrant Imlunestrant, a next-generation, brain-penetrant, oral selective estrogen receptor degrader (SERD) by Eli Lilly, is awaiting FDA approval for patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer
Less common but more serious side effects of GLP-1 agonists include: pancreatitis, an inflammation of the pancreas that causes abdominal pain gastroparesis, in which movement of food out of the stomach is slowed or stopped bowel obstruction, a blockage that keeps food from passing through the intestines gallstone attacks and bile duct blockage
This could lead to Ozempic heartburn
These data suggest that in chronic alcoholics with liver disease, GSH deficiency exists, which may predispose to further liver toxicity caused by resultant inadequate defense mechanisms
Studies suggest nutritional yeast may help lower cholesterol and support immunity, though more research is needed
